Skip to content
Journal

Journal of Pharmaceutical Research International

Published by SCIENCEDOMAIN international · ISSN (electronic) 2456-9119

Search within this journal

7,450

Articles indexed

84

2026 articles

7,450

Open access

23,857

Citations (indexed)

Publications by year

Articles (7450)

The Impact of Maturity on Role of Head and Eye on Ocular Motions to Intersection Scanning Conduct

Ateeq Rehman, Maqbool Ahmed Jamali, Nisar Ahmed Jandan, Muhammad Ashfaque Abbasi, Abbas Ali Ghoto & Arslan Ahmer · Journal of Pharmaceutical Research International · 2022

Objectives: The Objectives of researchers of this study are to find out if there was a relationship between age and the input of head and hand actions on scanning conduct at crossings. Impending junctions necessitates scanning a broad region, which necessitates big lateral head t...

Open access Research Article 10.9734/jpri/2022/v34i32A36107

Inflammatory Markers and the Metabolic Syndrome in Pakistan

Kinza Zafar, Hafiza Maryam Mushtaq & Zaryab Ali · Journal of Pharmaceutical Research International · 2022

The metabolic disorder has been conceptualized as a bunching of metabolic syndrome, including insulin obstruction, dyslipidemia, focal adiposity, and raised circulatory strain (BP) that increment risk for cardiovascular infection (CVD) and type 2 diabetes. The main objective of t...

Open access Research Article 10.9734/jpri/2022/v34i32A36108

Effects of Low Level Laser Therapy Vs Ultrasound Therapy in the Management of Active Trapezius Trigger Points

Abin Abraham Mammen, Deepak S Hegde & K. U. Dhanesh Kumar · Journal of Pharmaceutical Research International · 2022

Background: Trigger point is a extremely irritable local spot of exquisite tenderness in the nodule within the tangible taut muscle band. The prevalence studies have shown that the occurrence of myofascial trigger point in the general population. Objective: The aim of the study w...

Open access Research Article 10.9734/jpri/2022/v34i32A36109

A Phase II Open-Label Multi-center Trial of Isotoxic Hypofractionated Radiotherapy for NSCLC

Chunmei Liu, Qiang Lin, Huandi Zhou, Xiaohui Ge, Chaoxing Liu, Dongxue Gao, Yufeng Zhang & Xiaoying Xue · Journal of Pharmaceutical Research International · 2022

Background: The standard treatment for advanced unresectable non-small cell lung cancer (NSCLC) is concurrent chemoradiotherapy. However, many poor Karnofsky score or elderly patients cannot tolerate it due to heir serious side effects. For patients who cannot tolerate concurrent...

Open access Research Article 10.9734/jpri/2022/v34i32A36102

Etravirine Lipid Nanoparticles: Development and Validation Using Specific RP-HPLC Technique

Kunal Badrinarayan Banode, Veena Shailendra Belgamwar & Suchitra Shitla Mishra · Journal of Pharmaceutical Research International · 2022

Introduction: A common, exact & economical reverse phase-high performance liquid chromatographic approach for coinciding measurement of anti-retroviral medicine, Etravirine in the formulation of nanoparticle has been devised. This approach is a revolutionary analytical method...

Open access Research Article 10.9734/jpri/2022/v34i32A36103

Quality Assessment of Extemporaneously Compounded Carvedilol Oral Suspension for Pediatric Patients at the Hospital Pharmacy

Iman M. Alfagih, Alanood Almurshedi, Basmah Aldosari, Bushra Al Quadeib, Enas Zakaria, Eram Eltahir & Khadijh Alnakhli · Journal of Pharmaceutical Research International · 2022

Aims: The aim of this study was to evaluate different quality control parameters and the stability of the carvedilol compounded extemporaneous suspensions over three months at room temperature. Methodology: The carvedilol compounded extemporaneous suspensions were prepared in our...

Open access Research Article 10.9734/jpri/2022/v34i32A36104

Awareness and Knowledge of Coronary Heart Disease among the General Population: A Systematic Review

Kurnia Yogyanti, Susi Ari Kristina & Chairun Wiedyaningsih · Journal of Pharmaceutical Research International · 2022

Introduction: Coronary heart disease (CHD) is one of the cardiovascular diseases that become the leading cause of death (LCOD) in the United States. Knowledge gaps in CHD and its risk factors are significant obstacles to effective prevention and treatment. People's awareness of C...

Open access Research Article 10.9734/jpri/2022/v34i31B36098

Anxiety, Depression, Psychological Reaction and Impact of COVID 19 on Human Fertility

Mehwish Younus, Aruna Kumari Hira, Urooj Naz, Sana Shahmir, Uroosa Naz & Rabia Mazhar · Journal of Pharmaceutical Research International · 2022

Objective: The current study aim to understand the anxiety, depression, psychological reaction and impact of COVID-19 on human fertility in Karachi, Pakistan. Materials and Methods: This cross-sectional study was conducted on all married 243 patients at Out Patients Department (O...

Open access Research Article 10.9734/jpri/2022/v34i31B36101

Pulsatile Drug Delivery System (PDDS): A Cronotherapeutic Approach for Optimum Therapy

Santosh Kumar Dash, Ranjan Kumar Sahoo, Ashutosh Padhan, A. S. Khan, Nabin Karna, Naimish Nanda & Smrutiranjan Dash · Journal of Pharmaceutical Research International · 2022

Now a day’s PDDS are gaining more attraction and importance especially for the disease follow circadian rhythms. Some chronic disease like rheumatoid arthritis, asthma, hypercholesterolemia, hyper acidity and cardio vascular diseases where peak symptoms tends to follow a 24 hour...

Open access Research Article 10.9734/jpri/2022/v34i31B36094